Ocrelizumab treatment and disability progression in non-Hispanic Black and Hispanic or Latino individuals with relapsing multiple sclerosis: A post hoc analysis of the OPERA I and II trials
- DOI
- 10.1177/13524585261496124
- Published
- 2026-10-28
- Container
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/13524585261496124,
title = {Ocrelizumab treatment and disability progression in non-Hispanic Black and Hispanic or Latino individuals with relapsing multiple sclerosis: A post hoc analysis of the OPERA I and II trials},
author = {Lilyana Amezcua and Devi Sai Sri Kavya Boorgu and Jake Oxendine and Ibraheem Abioye and Tushar Bhangale and Christopher Harp and Chien-Ju Lin and Nicolas Strauli and Akshaya Ramesh and Bruce A. C. Cree and Mitzi J. Williams and Xiaoming Jia},
year = {2026},
journal = {Multiple Sclerosis Journal},
doi = {10.1177/13524585261496124},
url = {https://doi.org/10.1177/13524585261496124}
}RIS
TY - JOUR TI - Ocrelizumab treatment and disability progression in non-Hispanic Black and Hispanic or Latino individuals with relapsing multiple sclerosis: A post hoc analysis of the OPERA I and II trials AU - Lilyana Amezcua AU - Devi Sai Sri Kavya Boorgu AU - Jake Oxendine AU - Ibraheem Abioye AU - Tushar Bhangale AU - Christopher Harp AU - Chien-Ju Lin AU - Nicolas Strauli AU - Akshaya Ramesh AU - Bruce A. C. Cree AU - Mitzi J. Williams AU - Xiaoming Jia PY - 2026 JO - Multiple Sclerosis Journal DO - 10.1177/13524585261496124 UR - https://doi.org/10.1177/13524585261496124 ER -
APA
Amezcua, L., Boorgu, D. S. S. K., Oxendine, J., Abioye, I., Bhangale, T., Harp, C., Lin, C., Strauli, N., Ramesh, A., Cree, B. A. C., Williams, M. J., & Jia, X. (2026). Ocrelizumab treatment and disability progression in non-Hispanic Black and Hispanic or Latino individuals with relapsing multiple sclerosis: A post hoc analysis of the OPERA I and II trials. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585261496124
Source records
- crossref · retrieved 2026-11-11T04:26:38.909Z